Versant Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5K Sell
1,626
-469
-22% -$6.56K ﹤0.01% 1756
2026
Q1
$26.9K Buy
2,095
+525
+33% +$6.69K ﹤0.01% 1647
2025
Q4
$14.1K Sell
1,570
-125
-7% -$1.72K ﹤0.01% 1838
2025
Q3
$29.3K Hold
1,695
﹤0.01% 1352
2025
Q2
$15.9K Buy
1,695
+854
+102% +$7.01K ﹤0.01% 1651
2025
Q1
$5.98K Buy
841
+691
+461% +$6.98K ﹤0.01% 1966
2024
Q4
$1.75K Buy
+150
New +$2.34K ﹤0.01% 2084
2024
Q3
Sell
-85
Closed -$1.9K 2061
2024
Q2
$1.9K Buy
85
+68
+400% +$1.62K ﹤0.01% 1521
2024
Q1
$468 Sell
17
-10
-37% -$278 ﹤0.01% 1710
2023
Q4
$823 Buy
+27
New +$776 ﹤0.01% 1566
2023
Q3
Sell
-20
Closed -$816 2016
2023
Q2
$816 Buy
+20
New +$811 ﹤0.01% 1670

Other funds holding NTLA